Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in Refractory Metastatic Breast Cancer
NCT00080262Phase 2Completed
- Sponsor
- R-Pharm
- Start
- Feb 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of ixabepilone in breast cancer, sponsored by R-Pharm. Started Feb 2004; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00080262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080262.